ARCHIVES

NCI Intramural Budget: Well-Funded Labs, High Costs, Or Deceiving Appearances?

This article is from The Cancer Letter archive.

Vol. 21 No. 16 | April 21, 1995

Download PDF Visit The Full Archive

Related Articles

Organ Systems R01 Grants Doing Okay

February 8, 1985

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

June 27, 2008

Avon Awards $30M To 13 Organizations

September 27, 2002

Weight Gain After Diagnosis Increases Risk Of Death

December 28, 2007

Gene Vector Labs Seek Vector Producers

February 23, 1996